Shilpa Medicare’s OERIS Phase‑III Win Boosts CINV Market Share & ESG Edge
Shilpa Medicare’s Phase‑III success for OERIS™ and EcoVadis Gold ESG award signal strong growth, high‑impact oncology prospects, and sustainability leadership.
2 minutes to read